All studies
Active not recruitingOBSERVATIONAL

Cross-cultural Adaptation and Validation of the Localised Scleroderma Quality of Life Instrument (LoSQI) in Juvenile Localised Scleroderma (JLS)

Juvenile localised scleroderma (JLS) is a rare condition that causes patches of hardened skin and tissue in children and teenagers. While doctors track physical symptoms, understanding how the condition affects emotional health, school life, and social activities is just as vital. This international study focuses on perfecting and checking a questionnaire called the Localised Scleroderma Quality of Life Instrument (LoSQI). Researchers want to make sure the questions make sense to young people from different countries and cultures. Around 100 children and teenagers aged 8 to 18 will take part. By completing these surveys, participants help create a trusted tool that can be used in regular clinic visits and research studies worldwide. This will ensure that young people's voices and everyday experiences play a central role in guiding their medical care.

At a glance

Status
Active not recruiting
Sponsor
Istituto Giannina Gaslini
Enrolment target
272
Start
18 May 2022
Estimated completion
01 Dec 2026

What is this study about?

Juvenile localised scleroderma is a rare condition that causes areas of skin and the tissues beneath it to become hard, stiff, or discoloured. It can sometimes affect muscles and joints, making movement uncomfortable. Beyond physical changes, living with a visible skin condition can have a significant impact on how young people feel, their confidence, and their day-to-day activities at school and with friends.

At the moment, it can be tricky for doctors around the world to measure these emotional and social impacts in a standardised way. To help solve this, researchers have designed a special questionnaire called the Localised Scleroderma Quality of Life Instrument (LoSQI). This study focuses on translating and adapting the tool so it works well for children and teenagers across different countries and languages.

By taking part, young people and their parents help test the questions to ensure they are clear, relevant, and easy to answer. If successful, this project will give doctors a reliable way to listen to their patients' everyday experiences. It will also help scientists across the globe compare results in future research, leading to better support and treatment plans tailored to the whole child, not just their skin.

Key takeaways

  • Tests a new questionnaire designed to measure how scleroderma affects young people's everyday lives.
  • Open to children and teenagers aged 8 to 18 with juvenile localised scleroderma.
  • Does not involve any experimental drugs, blood tests, or changes to routine care.
  • Helps doctors and researchers worldwide better understand the emotional and social impact of the condition.
  • Participation is voluntary, and you can withdraw at any time.

Who may be eligible?

This study is open to children and teenagers aged 8 to 18 who have been diagnosed with juvenile localised scleroderma by a paediatric rheumatologist (a specialist doctor for children's joints and immune conditions). Participants need to be able to read and understand their native language at roughly an 8-year-old level so they can read through the questions.

Because this is about gathering young people's views directly, both the young person and their parent or guardian must be happy to take part. For those under 16, a parent will need to give formal permission, and the young person will give their agreement (assent).

Young people might not be able to join if they have another major long-term health condition that is unrelated to their scleroderma. This is to make sure that the answers given on the survey reflect the impact of scleroderma alone, rather than other health issues.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. The patient is between 8 and 18 years old.
  2. A specialist doctor (paediatric rheumatologist) has diagnosed juvenile localised scleroderma.
  3. The young person can read and understand their native language at roughly an 8-year-old level.
  4. Both the young person and a parent (if under 16) agree to take part.
  5. There are no other major, unrelated health conditions affecting the young person's daily life.
Answer every question to see your result.

What does participation involve?

Taking part in this study is straightforward and does not involve testing any new medicines, injections, or invasive medical procedures. Your usual NHS treatment and care will stay exactly the same throughout.

Instead, participation mainly involves completing questionnaires. Young people and their parents will be asked to read through the survey questions and share their thoughts on how clear, relevant, and easy they are to understand. You will then answer questions about how scleroderma affects daily life, such as mood, school, and friendships.

These surveys can often be completed during a regular clinic visit or at home, taking only a short amount of time. There are no extra hospital stays or follow-up drug monitoring appointments needed, and the study team will guide you through the process step by step.

Potential risks and benefits

There are no physical risks from taking part, as this study does not involve medications or blood tests. Some questions might touch on sensitive topics, such as feeling self-conscious or worried about skin changes, which could feel a bit uncomfortable for some young people. Taking part might not help your own condition directly, but it offers the satisfaction of helping other young people with scleroderma in the future. You are always free to step away from the study at any point without giving a reason, and your regular NHS medical care will not be affected in any way.

Locations (33)

  • Hospital Pedro de Elizalde
    Verified postcode
    Buenos Aires, Argentina
  • Hospital das Clínicas - Botucatu Medicine University, UNESP
    Verified postcode
    Botucatu, Brazil
  • Faculdade de Ciencias Medicas da UNICAMP
    Verified postcode
    Campinas, Brazil
  • University Hospital Pedro Ernesto
    Verified postcode
    Rio de Janeiro, Brazil
  • Universidade Federal de São Paulo
    Verified postcode
    São Paulo, Brazil
  • Children's hospital of Zhejiang University School of Medicine
    Verified postcode
    Hangzhou, China
  • University Hospital Centre Zagreb, University School of Medicine
    Verified postcode
    Zagreb, Croatia
  • Aarhus University Hospital
    Verified postcode
    Aarhus, Denmark
  • Ain Shams University
    Verified postcode
    Cairo, Egypt
  • Hamburg Centre for Pediatric and Adolescent Rheumatology
    Verified postcode
    Hamburg, Germany
  • University of Athens Medical School, Children Hospital Aghia Sophia
    Verified postcode
    Athens, Greece
  • SRCC Childrens Hospital
    Verified postcode
    Mumbai, India

Common questions

Will taking part involve testing new medicines or having blood tests?

No. This study only involves answering questions on paper or online. There are no new drugs, injections, or medical tests.

Will my normal hospital care change if I take part?

Not at all. Your regular appointments, treatments, and prescriptions will continue exactly as planned by your healthcare team.

How long does it take to complete the questionnaire?

The survey is designed to be short and child-friendly. It usually takes between 15 and 30 minutes to complete.

Can I stop taking part if I change my mind?

Yes. You can leave the study at any time without having to give a reason, and your medical team will support you just the same.

Are the answers kept private?

Yes. All personal information and survey answers are kept strictly confidential and stored securely in line with data protection rules.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.